- President of ETST’s partner for the manufacturing of Hygee attended fair with Quebec delegation
- Launch of Hygee, which tests women for sexually transmitted infections, is expected in first half of this year
- ETST recently launched an international marketing campaign for the device
Earth Science Tech Inc. (OTCQB: ETST), a biotech company that markets and develops hemp cannabinoid products, plans to introduce its Hygee medical testing kit in the first half of this year. As part of that strategy, the company showed Hygee at Arab Health 2019, the largest annual medical trade fair in the Middle East and North Africa (“MENA”) region (http://cnw.fm/zG2k1).
ETST has formed a strategic partnership for Hygee’s manufacture with Dermagate, a company that specializes in the production of dermatology and wound-care products. Gaétan Houle, president of Dermagate, represented ETST at Arab Health 2019 and was accompanied by an eight-company delegation organized by the Quebec Minister of the Economy and Innovation. Houle was also scheduled to attend a reception at the Canadian Consulate and meet with other Canadian trade ministers based in MENA countries.
Hygee is a medical self-sampling kit designed for women to use in the detection of STIs, starting with chlamydia. Dr. Michel Aubé, ETST’s CEO and chief science officer, said in a news release that the company’s goal at the show was to make key business contacts and connect to the MENA region’s health care industry and market.
In a news release, Houle said, “As previously announced, Hygee is on its way to being certified ISO-13485, and soon after, it will be licensed by the U.S. FDA and Health Canada. Moreover, ETST will apply for licensing Hygee in at least five other countries. This is notable, as many of North America’s largest medical device companies will attend Arab Health 2019, as will manufacturers and distributors from around the world.” An estimated 4,000 companies from 66 countries were scheduled to attend the fair, showing products and services to more than 84,000 visitors and nearly 6,000 dignitaries.
Based in Doral, Florida, ETST produces and sells CBD products, as well as dietary supplements for the pharmaceutical and nutraceutical fields. The company is focused on the cannabidiol, pharmaceutical and nutraceutical sectors, as well as the development, through subsidiaries, of medical devices and research. ETST’s goal is to become a world leader in the CBD space.
ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation Inc. is becoming a nonprofit and accepts grants and donations to conduct studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines, while Canna Inno Laboratories Inc. provides ETST with access to government grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000
For more information please visit https://www.cannabisnewswire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
